Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders.

× No keyword cloud information.

23 in total

1. A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal.

Authors: Travis W Grim; Cullen L Schmid; Edward L Stahl; Fani Pantouli; Jo-Hao Ho; Agnes Acevedo-Canabal; Nicole M Kennedy; Michael D Cameron; Thomas D Bannister; Laura M Bohn
Journal: Neuropsychopharmacology Date: 2019-08-23 Impact factor: 7.853

2. Current Practice in the Diagnosis of Bile Acid Diarrhea.

Authors: Priya Vijayvargiya; Michael Camilleri
Journal: Gastroenterology Date: 2019-03-05 Impact factor: 22.682

Review 3. Relamorelin for the treatment of gastrointestinal motility disorders.

Authors: Victor Chedid; Michael Camilleri
Journal: Expert Opin Investig Drugs Date: 2017-08-31 Impact factor: 6.206

Review 4. Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists.

Authors: Raj A Shah; Naim Alkhouri; Kris V Kowdley
Journal: Expert Opin Emerg Drugs Date: 2020-08-12 Impact factor: 4.191

5. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.

Authors: Deepti Jacob; Irene Busciglio; Duane Burton; Houssam Halawi; Ibironke Oduyebo; Deborah Rhoten; Michael Ryks; W Scott Harmsen; Michael Camilleri
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2017-08-16 Impact factor: 4.052

6. Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea.

Authors: Michael Camilleri; Sara Linker Nord; Duane Burton; Ibironke Oduyebo; Yiming Zhang; Jin Chen; Koeun Im; Prafulla Bhad; Michael K Badman; David S Sanders; Julian R F Walters
Journal: Aliment Pharmacol Ther Date: 2020-07-23 Impact factor: 8.171

7. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.

Authors: J R F Walters; I M Johnston; J D Nolan; C Vassie; M E Pruzanski; D A Shapiro
Journal: Aliment Pharmacol Ther Date: 2014-10-20 Impact factor: 8.171

Review 8. Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.

Authors: Joaquim Azevedo Neto; Anna Costanzini; Roberto De Giorgio; David G Lambert; Chiara Ruzza; Girolamo Calò
Journal: Molecules Date: 2020-08-25 Impact factor: 4.411

9. Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents.

Authors: Joel Castro; Sonia Garcia-Caraballo; Jessica Maddern; Gudrun Schober; Amanda Lumsden; Andrea Harrington; Shirdi Schmiel; Beatriz Lindstrom; John Adams; Stuart M Brierley
Journal: Pain Date: 2022-01-01 Impact factor: 6.961

1 in total

Review 1. Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders.

Authors: Rajan Singh; Hannah Zogg; Uday C Ghoshal; Seungil Ro
Journal: Front Pharmacol Date: 2022-01-25 Impact factor: 5.810

1 in total